Endothelial Dysfunction, Erectile Deficit and Cardiovascular Disease: An Overview of the Pathogenetic Links

被引:29
作者
De Leonardis, Federico [1 ]
Colalillo, Gaia [1 ]
Agro, Enrico Finazzi [1 ]
Miano, Roberto [1 ]
Fuschi, Andrea [2 ]
Asimakopoulos, Anastasios D. [3 ]
机构
[1] Univ Roma Tor Vergata, Dept Surg Sci, Unit Urol, I-00133 Rome, Italy
[2] Sapienza Univ Rome, Fac Pharm & Med, Dept Medicosurg Sci & Biotechnol, Urol Unit, I-04100 Latina, Italy
[3] Fdn PTV Policlin Tor Vergata, Unit Urol, I-00185 Rome, Italy
关键词
cardiovascular diseases; coronary artery disease; erectile dysfunction; endothelial dysfunction; CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; LOW SERUM TESTOSTERONE; RISK-FACTORS; SEXUAL ATTITUDES; MEN; PREVALENCE; PHYSIOLOGY; PREDICTION; PATHOPHYSIOLOGY;
D O I
10.3390/biomedicines10081848
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Erectile dysfunction (ED) is a condition with multifactorial pathogenesis, quite common among men, especially those above 60 years old. A vascular etiology is the most common cause. The interaction between chronic inflammation, androgens, and cardiovascular risk factors determines macroscopically invisible alterations such as endothelial dysfunction and subsequent atherosclerosis and flow-limiting stenosis that affects both penile and coronary arteries. Thus, ED and cardiovascular disease (CVD) should be considered two different manifestations of the same systemic disorder, with a shared aetiological factor being endothelial dysfunction. Moreover, the penile arteries have a smaller size compared with coronary arteries; thus, for the same level of arteriopathy, a more significant blood flow reduction will occur in erectile tissue compared with coronary circulation. As a result, ED often precedes CVD by 2-5 years, and its diagnosis offers a time window for cardiovascular risk mitigation. Growing evidence suggests, in fact, that patients presenting with ED should be investigated for CVD even if they have no symptoms. Early detection could facilitate prompt intervention and a reduction in long-term complications. In this review, we provide an overview of the pathogenetic mechanisms behind arteriogenic ED and CVD, focusing on the role of endothelial dysfunction as the common denominator of the two disorders. Developed algorithms that may help identify those patients complaining of ED who should undergo detailed cardiologic assessment and receive intensive treatment for risk factors are also analyzed.
引用
收藏
页数:13
相关论文
共 77 条
[1]   Reactive oxygen species and endothelial activation [J].
Alom-Ruiz, Sara P. ;
Anilkumar, Narayana ;
Shah, Ajay M. .
ANTIOXIDANTS & REDOX SIGNALING, 2008, 10 (06) :1089-1100
[2]   Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target [J].
Ambrosino, Pasquale ;
Grassi, Guido ;
Maniscalco, Mauro .
BIOMEDICINES, 2022, 10 (01)
[3]   Does Erectile Dysfunction Contribute to Cardiovascular Disease Risk Prediction Beyond the Framingham Risk Score? [J].
Araujo, Andre B. ;
Hall, Susan A. ;
Ganz, Peter ;
Chiu, Gretchen R. ;
Rosen, Raymond C. ;
Kupelian, Varant ;
Travison, Thomas G. ;
McKinlay, John B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (04) :350-356
[4]   Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study [J].
Banks, Emily ;
Joshy, Grace ;
Abhayaratna, Walter P. ;
Kritharides, Leonard ;
Macdonald, Peter S. ;
Korda, Rosemary J. ;
Chalmers, John P. .
PLOS MEDICINE, 2013, 10 (01)
[5]  
Barrett-Connor E, 2004, CLIN CARDIOL, V27, pI8
[6]   Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk [J].
Billups, K. L. ;
Miner, M. M. ;
Wierzbicki, A. S. ;
Jackson, G. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (02) :134-147
[7]   Erectile dysfunction as a marker for vascular disease [J].
Billups K.L. .
Current Urology Reports, 2005, 6 (6) :439-444
[8]   The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications [J].
Blann, AD ;
Yip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) :297-306
[9]   Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure A Double-Blind, Placebo-Controlled, Randomized Study [J].
Caminiti, Giuseppe ;
Volterrani, Maurizio ;
Iellamo, Ferdinando ;
Marazzi, Giuseppe ;
Massaro, Rosalba ;
Miceli, Marco ;
Mammi, Caterina ;
Piepoli, Massimo ;
Fini, Massimo ;
Rosano, Giuseppe M. C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (10) :919-927
[10]   A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases [J].
Carrizzo, Albino ;
Izzo, Carmine ;
Forte, Maurizio ;
Sommella, Eduardo ;
Di Pietro, Paola ;
Venturini, Eleonora ;
Ciccarelli, Michele ;
Galasso, Gennaro ;
Rubattu, Speranza ;
Campiglia, Petro ;
Sciarretta, Sebastiano ;
Frati, Giacomo ;
Vecchione, Carmine .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-40